For three colorectal cancer patients and three pancreatic cancer patients, the vaccine appeared to remove all disease ...

The FDA granted breakthrough device designation to Quest Diagnostics’ Haystack MRD test for patients with stage 2 colorectal ...

Sphincter-saving surgery is usually feasible as part of TME for patients with tumors in the mid and upper rectum. However, patients with distal rectal tumors have traditionally undergone APR with an ...

The FDA has granted breakthrough device designation to the Haystack MRD test, a circulating tumor DNA (ctDNA) test, for use ...

At data cutoff, 14 were still receiving treatment with dostarlimab and 103 had completed treatment, including 49 with rectal cancer and 54 with non-rectal solid tumors, which included esophageal ...

In the 20% of non-rectal cancer patients who still needed surgery post-therapy, researchers saw that the immunotherapy often shrunk the tumor and even lowered the stage classifications of some of ...

The phase 2 study (NCT04165772) involved 2 groups of patients, and investigators had already reported that the first 41 patients with rectal cancer experienced complete clinical responses. 4 The ...

Colibactin-producing E. coli is linked to increased colorectal cancer risk in Familial Adenomatous Polyposis patients, ...

In 20% of non-rectal cancer patients who still needed surgery post-therapy, researchers saw that the immunotherapy often shrank the tumor and even lowered the stage classifications of some of the ...

Colorectal cancer incidence has continued to rise in the U.S. A projected 154,270 cases will occur and 52,900 people in the country will die of the disease this year, according to American Cancer ...

A team led by Kim Ki-dong, a professor of obstetrics and gynecology at Seoul National University Bundang Hospital, announced ...

Preoperative tumor downstaging with CRT improves local control in rectal cancer but at the cost of higher toxicity and more late complications, observe the authors, including Theodor Junginger, MD ...